These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29142465)

  • 1. Efficacy of vinorelbine combined with low-dose methotrexate for treatment of inoperable desmoid tumor and prognostic factor analysis.
    Li S; Fan Z; Fang Z; Liu J; Bai C; Xue R; Zhang L; Gao T
    Chin J Cancer Res; 2017 Oct; 29(5):455-462. PubMed ID: 29142465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low-dose methotrexate combined with vinorelbine for inoperable desmoid tumor: efficacy and the prognostic factors].
    Fan Z; Li S; Fang Z; Liu J; Bai C; Xue R; Zhang L; Gao T
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):39-43. PubMed ID: 26806736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI.
    Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA
    Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral vinorelbine in young patients with desmoid-type fibromatosis.
    Kornreich L; Orbach D; Nicolas N; Brisse HJ; Berlanga P; Defachelles AS; Mansuy L; Verite C; Saumet L; Karanian M; Corradini N
    Tumori; 2023 Oct; 109(5):511-518. PubMed ID: 37114926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis.
    Palassini E; Frezza AM; Mariani L; Lalli L; Colombo C; Fiore M; Messina A; Casale A; Morosi C; Collini P; Stacchiotti S; Casali PG; Gronchi A
    Cancer J; 2017; 23(2):86-91. PubMed ID: 28410293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of extra - abdominal desmoid tumors with chemotherapy.
    Montgomery C; Emory C; Adams S; Cohen J; Pitcher JD; Potter BK; Temple HT
    Cancers (Basel); 2011 Aug; 3(3):3394-404. PubMed ID: 24212959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
    Toulmonde M; Pulido M; Ray-Coquard I; Andre T; Isambert N; Chevreau C; Penel N; Bompas E; Saada E; Bertucci F; Lebbe C; Le Cesne A; Soulie P; Piperno-Neumann S; Sweet S; Cecchi F; Hembrough T; Bellera C; Kind M; Crombe A; Lucchesi C; Le Loarer F; Blay JY; Italiano A
    Lancet Oncol; 2019 Sep; 20(9):1263-1272. PubMed ID: 31331699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998).
    Keus RB; Nout RA; Blay JY; de Jong JM; Hennig I; Saran F; Hartmann JT; Sunyach MP; Gwyther SJ; Ouali M; Kirkpatrick A; Poortmans PM; Hogendoorn PCW; van der Graaf WTA
    Ann Oncol; 2013 Oct; 24(10):2672-2676. PubMed ID: 23868907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study.
    Skapek SX; Anderson JR; Hill DA; Henry D; Spunt SL; Meyer W; Kao S; Hoffer FA; Grier HE; Hawkins DS; Raney RB
    Pediatr Blood Cancer; 2013 Jul; 60(7):1108-12. PubMed ID: 23281268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis.
    Napolitano A; Provenzano S; Colombo C; Vitellaro M; Brunello A; Badalamenti G; Nannini M; Ibrahim T; Hohenberger P; Gasperoni S; Gennatas S; Jones RL; Hindi N; Martin-Broto J; Spalato Ceruso M; Silletta M; Dei Tos AP; Gronchi A; Stacchiotti S; Santini D; Tonini G; Palassini E; Vincenzi B
    ESMO Open; 2020 Jan; 5(1):. PubMed ID: 31958289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis.
    Azzarelli A; Gronchi A; Bertulli R; Tesoro JD; Baratti D; Pennacchioli E; Dileo P; Rasponi A; Ferrari A; Pilotti S; Casali PG
    Cancer; 2001 Sep; 92(5):1259-64. PubMed ID: 11571741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
    Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y
    Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Outcomes of Oral Vinorelbine in Advanced, Progressive Desmoid Fibromatosis and Influence of
    Mir O; Honoré C; Chamseddine AN; Dômont J; Dumont SN; Cavalcanti A; Faron M; Rimareix F; Haddag-Miliani L; Le Péchoux C; Levy A; Court C; Briand S; Fadel E; Mercier O; Bayle A; Brunet A; Ngo C; Rouleau E; Adam J; Le Cesne A
    Clin Cancer Res; 2020 Dec; 26(23):6277-6283. PubMed ID: 32873570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical efficacy and safety of apatinib combined with chemotherapy for osteosarcoma and soft tissue sarcoma with pulmonary metastasis].
    Li SL; Yang QK; Chen P; Zheng K; Wang W; Pei Y; Zhang XJ
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):309-314. PubMed ID: 31014058
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review.
    Tsukamoto S; Takahama T; Mavrogenis AF; Tanaka Y; Tanaka Y; Errani C
    Musculoskelet Surg; 2023 Mar; 107(1):7-18. PubMed ID: 35150408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Timely Oral Option: Single-Agent Vinorelbine in Desmoid Tumors.
    Gennatas S; Chamberlain F; Smrke A; Stewart J; Hayes A; Roden L; Messiou C; Kowa JY; Estival A; Chauhan D; Thway K; Fisher C; van der Graaf WTA; Jones RL; Benson C
    Oncologist; 2020 Dec; 25(12):e2013-e2016. PubMed ID: 32918789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children.
    Skapek SX; Hawk BJ; Hoffer FA; Dahl GV; Granowetter L; Gebhardt MC; Ferguson WS; Grier HE
    J Clin Oncol; 1998 Sep; 16(9):3021-7. PubMed ID: 9738571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
    Krzakowski M; Provencio M; Utracka-Hutka B; Villa E; Codes M; Kuten A; Henke M; Lopez M; Bell D; Biti G; Merimsky O; Beorchia A; Riggi M; Caux NR; Pouget JC; Dubray B; David P
    J Thorac Oncol; 2008 Sep; 3(9):994-1002. PubMed ID: 18758302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of desmoid tumors and fibromatosis using vinorelbine.
    Weiss AJ; Horowitz S; Lackman RD
    Am J Clin Oncol; 1999 Apr; 22(2):193-5. PubMed ID: 10199460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmoid-type fibromatosis in children. Clinical features, treatment response, and long-term follow-up.
    Fortunati D; Kaplan J; López Martí J; Ponzone A; Innocenti S; Fiscina S; Cacciavillano W; Zubizarreta P; Rose A
    Medicina (B Aires); 2020; 80(5):495-504. PubMed ID: 33048794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.